Reasons why older adults in three countries agreed with a deprescribing recommendation in a hypothetical vignette.

Basic Clin Pharmacol Toxicol

Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Published: December 2023

The purpose of this study was to examine factors important to older adults who agreed with a deprescribing recommendation given by a general practitioner (GP) to a hypothetical patient experiencing polypharmacy. We conducted an online, vignette-based, experimental study in the United Kingdom, United States and Australia with participants ≥65 years. The primary outcome was an agreement with a deprescribing recommendation (6-point Likert scale; 1 = strongly disagree and 6 = strongly agree). We performed a content analysis of the free-text reasons provided by participants who agreed with deprescribing (score of 5 or 6). Among 2656 participants who agreed with deprescribing, approximately 53.7% shared a preference for following the GP's recommendation or considered the GP the expert. The medication was referred to as a reason for deprescribing by 35.6% of participants. Less common themes included personal experience with medicine (4.3%) and older age (4.0%). Older adults who agreed with deprescribing in a hypothetical vignette most frequently reported a desire to follow the recommendations given the GP's expertise. Future research should be conducted to help clinicians efficiently identify patients who have a strong desire to follow the doctor's recommendations related to deprescribing, as this may allow for a tailored, brief deprescribing conversation.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.13857DOI Listing

Publication Analysis

Top Keywords

agreed deprescribing
20
older adults
12
deprescribing recommendation
12
deprescribing
9
hypothetical vignette
8
adults agreed
8
participants agreed
8
desire follow
8
agreed
5
reasons older
4

Similar Publications

The Attitudes Toward Polypharmacy and Willingness to Deprescribe Among Patients with Multimorbidity in Rural Areas of Shandong Province in China: A Cross-Sectional Study.

Patient Prefer Adherence

December 2024

Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

Purpose: Multimorbidity and polypharmacy have emerged as significant global issues, heightening the risks of potentially inappropriate medications (PIMs). This necessitates medication optimization through deprescribing. Understanding patients' decision-making preferences regarding medication cessation is crucial for mitigating medication-related risks.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical practice guidelines (CPGs) for diabetes management face challenges in older adults due to factors like frailty and multiple health issues.
  • * The systematic review analyzed 23 CPGs from the last decade, focusing on HbA1c targets and treatment recommendations for older and frail individuals.
  • * Results showed most CPGs recommend stricter HbA1c targets for healthier older adults, while suggesting more lenient targets for frail individuals, though there's variability in pharmacotherapy advice, especially for frail patients.
View Article and Find Full Text PDF

A Nursing Home Clinician Survey to Explain Gabapentinoid Increases.

J Am Med Dir Assoc

January 2025

Department of Family Medicine and Population Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA; Larry A. Green Center, Richmond, VA, USA.

Objectives: Survey nursing home (NH) clinicians about the indications for NH gabapentinoid use, the factors driving increased prescribing, and their experiences with gabapentinoid deprescribing.

Design: Online clinician survey.

Setting And Participants: NH clinicians prescribing gabapentinoids in US NHs.

View Article and Find Full Text PDF

Recommendations for Deprescribing of Medication in the Last Phase of Life: An International Delphi Study.

J Pain Symptom Manage

November 2024

Department of Medical Oncology (E.E.C.M.E., I.E.P., E.C.T.G., C.C.D.V.D.R.), Erasmus Medical Center, Cancer Institute Rotterdam, Netherlands.

Context: Medications may become inappropriate for patients in the last phase of life and may even compromise their quality of life.

Objective: To find consensus on recommendations regarding deprescribing of medications for adult patients with a life expectancy of six months or less.

Methods: Experts working in palliative care or other relevant disciplines were asked to participate in this international Delphi study.

View Article and Find Full Text PDF

Background: Sustainable implementation of new professional services into clinical practice can be difficult. In 2019, a population-wide initiative called SaferMedsNL was implemented across the province of Newfoundland and Labrador (NL), to promote appropriate medication use. Two evidence-based interventions were adapted to the context of NL to promote deprescribing of proton pump inhibitors and sedatives.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!